Givinostat

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 149 publications

From design to clinic: Medicinal chemistry and pharmacology of approved epigenetic drugs.

From design to clinic: Medicinal chemistry and pharmacology of approved epigenetic drugs.

Journal: European journal of medicinal chemistry

Published: May 19, 2026

Structure evaluation coupled with all-atom molecular dynamics and advanced quantum mechanical DFT revealed kaempferol as a potent binding flavonol for the epigenetic-target HDAC9.

Structure evaluation coupled with all-atom molecular dynamics and advanced quantum mechanical DFT revealed kaempferol as a potent binding flavonol for the epigenetic-target HDAC9.

Journal: Journal of biosciences

Published: May 08, 2026

Real-world safety profile of givinostat: an early post-marketing pharmacovigilance study based on the FAERS database.

Real-world safety profile of givinostat: an early post-marketing pharmacovigilance study based on the FAERS database.

Journal: Frontiers in pharmacology

Published: April 21, 2026

Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy.

Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy.

Journal: BMC pharmacology & toxicology

Published: April 17, 2026

Treatment advances for Duchenne muscular dystrophy.

Treatment advances for Duchenne muscular dystrophy.

Journal: Current opinion in pediatrics

Published: April 01, 2026

Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update.

Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update.

Journal: Expert opinion on pharmacotherapy

Published: March 30, 2026

Corrigendum to "Givinostat rescues folding of cystathionine beta-synthase and ameliorates murine homocystinuria" [Biochem. Pharmacol. 239 (2025) 117079].

Corrigendum to "Givinostat rescues folding of cystathionine beta-synthase and ameliorates murine homocystinuria" [Biochem. Pharmacol. 239 (2025) 117079].

Journal: Biochemical pharmacology

Published: February 28, 2026

Safety and Tolerability of Givinostat: Evidence From Real-World and Clinical Practice.

Safety and Tolerability of Givinostat: Evidence From Real-World and Clinical Practice.

Journal: Annals of clinical and translational neurology

Published: January 27, 2026

Corticosteroid treatment in Duchenne muscular dystrophy.

Corticosteroid treatment in Duchenne muscular dystrophy.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: December 14, 2025

Cardiac surveillance in the era of Duvyzat: do we need to do more?

Cardiac surveillance in the era of Duvyzat: do we need to do more?

Journal: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology

Published: December 09, 2025

Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model.

Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model.

Journal: Biological & pharmaceutical bulletin

Published: November 30, 2025

Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers.

Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers.

Journal: Clinical pharmacology in drug development

Published: November 24, 2025

Showing 1-12 of 149

Last Updated: 09/26/2026